Manuel Hidalgo 🇪🇸 🇺🇸
@DrMhidalgo
Followers
2K
Following
2K
Media
23
Statuses
3K
Professor of Medicine. Chief of Hem/Onc at Weill Cornell Medicine/New York Presbyterian Hospital. Pancreatic cancer researcher. Opinions are mine.
New York, USA, Madrid, Spain
Joined March 2013
RT @GCAResearch: We’re thrilled to unveil the official trial name and logo of GCAR’s forthcoming pancreatic cancer clinical trial! 📣. IMPAC….
0
3
0
RT @WeillCornell: Announcing the launch of the Weill Cancer Hub East, bringing together experts from @Princeton, @RockefellerUniv, Weill Co….
0
32
0
RT @DrSarcoma: All terrific additions to our leadership team @AACR. Thanking them all in advance for their service in support of helping t….
0
1
0
RT @AACR_CEO: Dr. Flaherty’s remarkable work in developing targeted therapies for the treatment of melanoma has had an incredible impact on….
0
2
0
Congratulations to our daughter Sofia who matched at HSS to do orthopedic surgery. Super proud. Keep up the good work!
47
31
1K
0
1
0
RT @christinemphmd: Celebrating the incredible women of @WeillCornell Hematology & Oncology! Our #HemeOnc Women Physicians’ Group spring me….
0
13
0
RT @AACR_CEO: Dr. Siu’s visionary leadership as a researcher and clinician has led to transformative advancements in cancer research and pa….
0
5
0
Congratulations!.
It’s official! It is my absolute privilege to be named as the Director of the Moores Comprehensive Cancer Center at UCSD Health. I am looking forward to advancing efforts in cancer based on an approach of collaboration and excellence.
0
0
7
Welcome!.
Happy #MatchDay! We are thrilled to welcome our incoming heme/onc fellows! And finally launch our @WCMHemOncFellow account! @WCM_MeyerCancer @WCMDeptofMed @WeillCornell @AGomez_MD.
0
0
6
RT @christinemphmd: Excited to share that our @WeillCornell hematology & oncology fellowship program is expanding! . We will be recruiting….
0
14
0
Amazing! Congratulations!.
I am excited to share we have received the NoA of an R01, converted to the prestigious MERIT R37. Grateful for the @NIH @theNCI's funding for the next 7 years! This will support our work on targeting APOBEC3 cytidine deaminases as drivers of resistance in #bladdercancer
0
0
3
RT @jbuell01: Brilliant & novel benefit in MSS CRC; A combo trial in 2L gastric with BOT + @MiNK_iNKT to start soon! @oncogenejournal @pas….
0
3
0
RT @WCMGIcancer: Rain or shine! We’re proud to support @PanCAN and walk alongside and in honor of #PancreaticCancer patients and loved ones….
0
4
0
RT @pashtoonkasi: Hello friends!. 🍴Dine/Order Online at the best Italian Restaurant in the state of NY🗽& support our #Cancer #Research. 👇🏾….
0
8
0
RT @BrunoBockorny: ORR was 33% with Bot/Bal, we are very excited with these results, and this population was heavily pre-treated, median of….
0
7
0
RT @gadorjoya: Hoy me despido de la Asamblea de Madrid. Doy gracias por las personas que he encontrado en estos cuatro años, todas me han a….
0
220
0
RT @OncLive: First-line Zolbetuximab Plus CAPOX Prolongs Survival in CLDN18.2+/HER2– Unresectable Locally Advanced or Metastatic Gastric/GE….
0
2
0